IPO

Seminole Gaming & Hard Rock tap veteran execs from Bellagio and MGM to lead key properties and spearhead their ambitious Las Vegas expansion.

Following massive asset sales and billions in dividends, Array Digital reports surging tower revenue and an optimistic forecast for its new 5G future.

After selling its wireless unit, TDS reports soaring profits and announces aggressive new growth targets for its fiber broadband and tower businesses.

Bitdeer leverages complex financial deals to refinance debt and fund a major expansion into the booming AI and high-performance computing market.

The junior explorer secures crucial funding from a renowned investor, fueling its nickel-copper ambitions in Canada's critical mineral heartland.

Ramsay Health Care will distribute its 52.79% stake in its European arm, setting the stage for a new era of autonomy and strategic focus for the group.

Telehealth firm MangoRx reports explosive growth with its $99/month TRT program, challenging competitors and raising questions about the future of virtual care.

Weave posts strong 2025 results, leveraging AI and key partnerships with CareCredit and the ADA to redefine the healthcare practice front office.

Facing delisting, the Singaporean tech firm enacts a 1-for-20 reverse split. Is it a lifeline or a sign of deeper financial troubles ahead?

Cybersecurity leader KnowBe4 appoints Yuneeb Khan as CFO, signaling a strategic focus on scaling its AI-driven human risk management platform.

Kurv's new KCOP ETF offers investors a unique way to play the copper market, combining mining exposure with an options strategy for enhanced income.

The rapidly growing gold producer uplists to the NYSE, backed by strong production, major expansion projects, and a strategy to double output in South America.

Xtreme One Entertainment's OTCQB uplist signals a new era for its XFC brand, aiming to boost investor trust and fund its 'minor league' MMA growth.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

After a volatile market debut, the supersonic flight company hits the NYSE, signaling a new era for high-speed testing and air-launch services.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

YETI hires Scott Bomar, a retail finance expert from Home Depot, signaling a strategic focus on operational efficiency and global expansion.

ICANN's 2026 domain expansion offers Turkish firms a rare chance to claim new digital real estate. But is the opportunity worth the significant cost?